Related Experiment Video
Updated: Jul 19, 2026

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva
Published on: July 5, 2017
COVID-19 and conjunctivitis: a meta-analysis
1School of Health and Social Care, Oulu University of Applied Sciences, Kiviharjuntie 8, 90220 Oulu Teuvo, Pakkalan Katu 19, 90100 Oulu, 90220, Finland.
Insights
Conjunctivitis is a common ocular symptom in COVID-19 patients. This meta-analysis found a low odds ratio for conjunctivitis in COVID-19 cases, synthesizing current evidence.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Public Health
Background:
- COVID-19, caused by SARS-CoV-2, has led to millions of cases and deaths globally.
- Ocular manifestations, including conjunctivitis, have been observed in both adult and pediatric COVID-19 patients.
Purpose of the Study:
- To conduct a meta-analysis estimating the odds ratio (ORs) of conjunctivitis in patients diagnosed with COVID-19.
- To synthesize current evidence on the association between COVID-19 and conjunctivitis.
Main Methods:
- A systematic review and meta-analysis were performed.
- Literature searches were conducted using PubMed and Google Scholar databases.
- Data from 20 studies, including 3383 participants, were analyzed to determine the ORs of conjunctivitis.
Main Results:
- The meta-analysis included 20 studies with 3383 participants.
- The overall odds ratio for conjunctivitis in COVID-19 patients was 0.01 (95% CI: 0.00-0.02).
- No significant bias was reported in the included studies.
Conclusions:
- Conjunctivitis is a frequent ocular finding in adult COVID-19 patients.
- This meta-analysis quantifies the link between COVID-19 and conjunctivitis, noting significant heterogeneity in current research.
- The study provides a consolidated review of available literature on COVID-19 and conjunctivitis in all age groups.
Abstract:
COVID-19 is a disease first identified in Wuhan City, Hubei Province, China, in December 2019, causes by a SARS-COV-2 virus infection. By 27 October 2020, 43,921,473 confirmed cases were reported worldwide, with 1,166,389 COVID-19 deaths. Conjunctivitis has been reported in adults and pediatric patients with COVID-19.
Objective:
The aim of this meta-analysis is to estimate the odd Ratio (ORs) of conjunctivitis in patients with COVID-19.
Methods:
A systematic review and meta-analysis have been performed using the PubMed and Google Scholar literature search. The ORs of conjunctivitis in adults and pediatric patients is the outcome of this meta-analysis.
Results:
There have been 1041 articles published since the outbreak in December 2019, according to the latest literature. For the meta-analysis, 20 studies with a total of 3383 participants were included. The odds ratio (ORs) of conjunctivitis was 0.01 (95% confidence interval [CI]: 0.00-0.02). No bias has been reported.
Conclusion:
Conjunctivitis is the most common ocular manifestations reported in adults. This comprehensive meta-analysis quantifies the existing evidence linking conjunctivitis with COVID-19 and highlights the high percentage of heterogeneity that is shown in the current studies. Finally, it offers a single review article which includes all the current articles available for COVID-19 and conjunctivitis in adults and children.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Microbiome of the Eye
Cytomegalovirus Disease
Coronavirus

